ENvue Medical, Inc. 8-KCurrent Reports (8-K / ad hoc)

Market for Equity / Stockholders

Item 5.07. Submission of Matters to a Vote of Security Holders. On August 14, 2026, ENvue Medical, Inc. (the “ Company ”) held a special meeting of stockholders (the “ Special Meeting ”). The final voting results of the Special Meeting are set forth below. Stockholders voted on the following proposals: Proposal No. 1: Reverse Stock Split Proposal The stockholders voted to approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of the Company’s Board of Directors (the “ Board ”) but prior to the one-year anniversary of the Special Meeting, a reverse stock split of all of the outstanding shares of the Company’s common stock, at a ratio in the range of 1-for-2 to 1-for-50, with such ratio to be determined by the Board in its discretion and included in a public announcement. The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis): For Against Abstain 3,847,974 1,062,981 19,288 Proposal No. 2: Adjournment Proposal The stockholder voted to approve an adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of any one or more of the proposals presented at the Special Meeting (the “ Adjournment Proposal ”). The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis): For Against Abstain 4,199,681 594,319 136,243 Although the Adjournment Proposal received sufficient votes to be approved, no motion to adjourn the Special Meeting was made because the adjournment of the Special Meeting was determined not to be necessary or appropriate. The results reported above are final voting results. No other matters were considered or voted upon at the Special Meeting. Field: Page; Sequence: 2 Field: /Page SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 14, 2026 ENVUE MEDICAL, INC. By: /s/ Doron Besser, M.D. Name: Doron Besser, M.D. Title: Chief Executive Officer Field: Page; Sequence: 3; Options: Last Field: /Page Field: Set; Name: xdx; ID: xdx_08B_extensions eJxFjdEKwjAMRb9g/xD6PHQrKrJHxxRxigwRX4vLpLg1I61zfpJ/ad0QQyAk955cIUKxobWukeGy